Abstract
BackgroundIntracoronary (IC) injection of bone marrow mononuclear cells (BMMNCs) is a promising treatment for heart failure. However, therapeutic effects in clinical studies have been small and a principle reason may...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
